GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tauns Laboratories Inc (TSE:197A) » Definitions » Additional Paid-In Capital

Tauns Laboratories (TSE:197A) Additional Paid-In Capital : 円2,633 Mil(As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tauns Laboratories Additional Paid-In Capital?


Tauns Laboratories's quarterly additional paid-in capital declined from Mar. 2024 (円2,783 Mil) to Jun. 2024 (円2,633 Mil) but then stayed the same from Jun. 2024 (円2,633 Mil) to Dec. 2024 (円2,633 Mil).

Tauns Laboratories's annual additional paid-in capital stayed the same from Jun. 2022 (円2,758 Mil) to Jun. 2023 (円2,758 Mil) but then declined from Jun. 2023 (円2,758 Mil) to Jun. 2024 (円2,633 Mil).

Tauns Laboratories Additional Paid-In Capital Historical Data

The historical data trend for Tauns Laboratories's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tauns Laboratories Additional Paid-In Capital Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24
Additional Paid-In Capital
2,758.30 2,758.30 2,633.30

Tauns Laboratories Quarterly Data
Jun22 Jun23 Mar24 Jun24 Dec24
Additional Paid-In Capital 2,758.30 2,758.30 2,783.30 2,633.30 2,633.30

Tauns Laboratories Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Tauns Laboratories Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Tauns Laboratories's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Tauns Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tauns Laboratories Inc (TSE:197A) » Definitions » Additional Paid-In Capital
Comparable Companies
TSE:5889 TSE:262A TSE:7749 TSE:7979 TSE:7780 TSE:3593 TSE:3154 TSE:7743 TSE:7775 TSE:7702 ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN
Traded in Other Exchanges
N/A
Address
761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Website
https://www.tauns.co.jp/en
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.

Tauns Laboratories Headlines

No Headlines